216 related articles for article (PubMed ID: 23512831)
1. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.
Dupuis LL; Boodhan S; Holdsworth M; Robinson PD; Hain R; Portwine C; O'Shaughnessy E; Sung L;
Pediatr Blood Cancer; 2013 Jul; 60(7):1073-82. PubMed ID: 23512831
[TBL] [Abstract][Full Text] [Related]
2. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients.
Dupuis LL; Robinson PD; Boodhan S; Holdsworth M; Portwine C; Gibson P; Phillips R; Maan C; Stefin N; Sung L;
Pediatr Blood Cancer; 2014 Aug; 61(8):1506-12. PubMed ID: 24753095
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness research in antineoplastic-induced nausea and vomiting control in children.
Flank J; Dupuis LL
J Comp Eff Res; 2014 Mar; 3(2):185-96. PubMed ID: 24645692
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
[TBL] [Abstract][Full Text] [Related]
5. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.
Dupuis LL; Boodhan S; Sung L; Portwine C; Hain R; McCarthy P; Holdsworth M;
Pediatr Blood Cancer; 2011 Aug; 57(2):191-8. PubMed ID: 21465637
[TBL] [Abstract][Full Text] [Related]
6. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
7. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
8. [Management of emesis in cancer patients].
Slimane K; Perez A; Ruffié P; di Palma M
Bull Cancer; 2004 May; 91(5):403-8. PubMed ID: 15281279
[TBL] [Abstract][Full Text] [Related]
9. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
[TBL] [Abstract][Full Text] [Related]
10. Practical management of chemotherapy-induced nausea and vomiting.
Wiser W; Berger A
Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
[TBL] [Abstract][Full Text] [Related]
11. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study.
Jacknow DS; Tschann JM; Link MP; Boyce WT
J Dev Behav Pediatr; 1994 Aug; 15(4):258-64. PubMed ID: 7798371
[TBL] [Abstract][Full Text] [Related]
12. Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis.
Patel P; Paw Cho Sing E; Dupuis LL
Expert Opin Drug Saf; 2019 Feb; 18(2):97-110. PubMed ID: 30640557
[TBL] [Abstract][Full Text] [Related]
13. Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types.
Aapro MS; Schmoll HJ; Jahn F; Carides AD; Webb RT
Cancer Treat Rev; 2013 Feb; 39(1):113-7. PubMed ID: 23062719
[TBL] [Abstract][Full Text] [Related]
14. Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
Massaro AM; Lenz KL
Ann Pharmacother; 2005 Jan; 39(1):77-85. PubMed ID: 15562136
[TBL] [Abstract][Full Text] [Related]
15. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
Balu S; Buchner D; Craver C; Gayle J
Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
[TBL] [Abstract][Full Text] [Related]
16. Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Ruhlmann CH; Herrstedt J
Expert Rev Anticancer Ther; 2012 Feb; 12(2):139-50. PubMed ID: 22316362
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
Chan A; Tan SH; Low XH; Yap KY
Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
[TBL] [Abstract][Full Text] [Related]
18. [Nausea and vomiting in cancer patients].
Lévy E; Scotté F; Médioni J; Oudard S
Rev Prat; 2006 Nov; 56(18):2015-9. PubMed ID: 17274504
[TBL] [Abstract][Full Text] [Related]
19. A survey of antiemetic use in children with cancer.
van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of nausea and vomiting in clinical oncology.
Briscoe K
Oncology (Williston Park); 1989 Aug; 3(8 Suppl):11-5. PubMed ID: 2701574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
